Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.415
BATS BZX Real-Time Price
As of 9:56am ET
 +0.0048 / +1.17%
Today’s Change
0.39
Today|||52-Week Range
6.96
-75.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$68.0M

Company Description

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of pharmaceutical product candidates that focuses on the treatment of obesity. Its sole product, Contrave, functions as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. The company was founded Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Contact Information

Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court
La Jolla California 92037
P:(858) 875-8600
Investor Relations:

Employees

Shareholders

Other institutional42.98%
Individual stakeholders31.98%
Mutual fund holders26.68%

Top Executives

Michael A. NarachiPresident, CEO, CFO & Inside Director
Thomas R. CannellChief Commercial Officer & Executive VP
Thomas P. LynchSecretary, Executive VP & General Counsel
Preston S. KlassenExecutive Vice President-Global Development
Jason KeyesVice President-Finance